Insight

Oct 7, 2024, 16:46

Outcomes in patients with oligoprogression following 1st line IO or ChemoIO

Gerry Hanna, Radiation Oncologist at St James’s Hospital, shared a post on X:

“Very intresting paper by Lauren Julia Brown, Harriet Gee, Eric Hau from Australia. They report outcomes in patients with oligoprogression following 1st line IO or ChemoIO.
Patients who receive radiotherapy have better survival.
Paper link on JTO & JTO CRR.”

Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study

Authors: Lauren Julia Brown, et al.

Source: Gerry Hanna/X

cancer cancer awareness cancer care Dublin Eric Hau fight against cancer Gerry Hanna Global fight against cancer Harriet Gee JTO & JTO CRR Lauren Julia Brown NSCLC OncoDaily Oncology radiotherapy St James's Hospital

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage